I. Scope and time of implementation
Scope of medical institutions
All public medical institutions in Fujian Province participate, and designated medical institutions with medical insurance can participate on the basis of further improving the management of drug purchase, sale and storage and ensuring timely settlement of drug expenses.
Drug range
This time, the selected varieties determined by the centralized drug procurement organized by the state were implemented.
Procurement cycle
According to the procurement cycle uniformly determined by the National Joint Procurement Office, the cycle is 2 years from the date of formal implementation of the selected results.
Second, raise the price limit and medical insurance payment standard.
The drugs selected in the centralized drug procurement organized by the state are sold at zero difference rate, and the sales price is used as the payment standard of medical insurance.
Non-selected drugs belong to the centralized procurement of drugs organized by the state and are sold at a zero-difference rate that does not exceed the maximum sales price limit.
1. The medical insurance payment standard for drugs in the competition group shall be determined according to the same generic name and the lowest winning price in the same group;
2. The payment standard of medical insurance for non-competitive drugs is temporarily determined by 70% of the sales price, with the lowest bid price of the same generic name and the same group as the bottom. If the sales price is not higher than the same generic name and the lowest bid price in the same group, the sales price is the medical insurance payment standard.
3. The medical insurance payment standard for centralized procurement of drugs with the same generic name without hanging the net shall be determined according to the minimum payment standard for selecting products with the same generic name.
Third, clear the implementation time.
The successful results will be implemented on May 6, 2022.
From May 9th, the selected drugs with the same generic name and the non-selected drugs will simultaneously implement the prescribed sales price and differentiated medical insurance payment standard. Medical insurance agencies and medical institutions at all levels should timely adjust the medical insurance information system and the hospital information system of medical institutions.
Four. Expected results of centralized procurement
This collection covers 16 generic varieties of second-generation and third-generation insulin commonly used in clinic, and the average price of selected products is reduced by 48%.
Taking insulin glargine commonly used in clinic as an example, the average cost of insulin glargine is reduced from 180 yuan to about 4,000 yuan per 70 yuan, and each patient can save about 4,000 yuan per year. It is estimated that after centralized procurement, Fujian Province can save 1.85438+0 billion yuan every year.